address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,cryptoTradeable,regularMarketChangePercent,regularMarketPrice,marketState,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,shortName,longName,trailingPegRatio
Klara Norra Kyrkogata 26,Stockholm,111 22,Sweden,46 86 79 72 10,https://www.egetis.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Egetis Therapeutics AB (publ), a pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment. The company's products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol overdose, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of monocarboxylate transporter 8 (MCT8) deficiency, a debilitating rare disease with no available treatment. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.",38,"[{'maxAge': 1, 'name': 'Mr. Nicklas  Westerholm', 'age': 48, 'title': 'Chief Executive Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 4800000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Torsten  Almén', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ingemar  Lundström Ph.D.', 'age': 81, 'title': 'Founder', 'yearBorn': 1943, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Louis Joseph Ignarro Ph.D.', 'age': 82, 'title': 'Founder', 'yearBorn': 1942, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Associate Prof. Heidi  Brurok', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Rob  Towart', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Yilmaz  Mahshid Ph.D.', 'age': 45, 'title': 'Chief Financial Officer', 'yearBorn': 1979, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Katayoun  Welin-Berger Ph.D.', 'age': 56, 'title': 'Vice President of Operations', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Karl  Hard Ph.D.', 'age': 62, 'title': 'Head of Investor Relations & Business Development', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Laetitia  Szaller L.L.M.', 'title': 'General Counsel & Head of Compliance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]",1672444800,[],86400,2,5.41,5.41,5.37,5.59,5.41,5.41,5.37,5.59,0.0,1.072,45.333336,463246,463246,552665,270365,270365,5.41,5.45,1954254848,3.025,7.67,41.847,4.0051,4.8335,0.0,0.0,SEK,False,1477214464,0.0,182047513,359238016,0.3359,0.30634,359238016,1.206,4.5107794,1735603200,1767139200,1743379200,-331500000,-1.0,0.12,31.632,-4.69,-0.082845986,0.10611236,EQUITY,5.44,15.0,10.0,12.0,11.5,none,4,272800000,0.759,-315000000,106500000,1.508,1.533,46700000,24.579,0.144,-0.27921,-0.73186994,28100000,-124725000,-238600000,0.05,0.60171,0.0,-5.10236,SEK,EGTX.ST,en-US,US,Equity,Delayed Quote,True,HIGH,[],1752852571,STO,finmb_33840529,Europe/Stockholm,CEST,7200000,se_market,False,0.60650015,0.12547846,15,0,False,0.5545325,5.44,CLOSED,False,1302159600000,0.03000021,5.37 - 5.59,Stockholm,552665,2.415,0.79834706,3.025 - 7.67,-2.23,-0.29074314,-8.284598,1755752400,1755752400,1755752400,1746000000,1746000000,False,-1.0,0.12,-0.9278,-5.8633327,1.4349003,0.3582683,Egetis Therapeutics AB,Egetis Therapeutics AB (publ),
